Prenatal Opioid Exposure Linked to Childhood Hospitalization
A new study found that maternal opioid use during pregnancy is associated with a higher risk of hospital admission for young children.
Updated on Oct. 13, 2026 in Pregnancy
Live Poll
Should medical providers further restrict opioid prescriptions for pregnant women based on new safety data?
Children exposed to maternal opioid prescriptions during pregnancy face a 28% higher rate of hospital admission. This increased risk is most significant for children up to five years of age.
Why it matters
The findings suggest that prenatal opioid exposure may disrupt infant development and immune system function, indicating a need for targeted health monitoring for these children. Researchers observed higher hospital admission rates for various infections, as well as respiratory, gastrointestinal, and genitourinary conditions.
The study analyzed health data for 2,928,186 children born between 2010 and 2017. Results showed that high maternal opioid doses correlate with a 1.40 adjusted incidence rate ratio for hospital admission, compared to 1.19 for low-dose exposure.
The players
PLOS Medicine
This is a peer-reviewed, open-access medical journal that publishes original research in the field of medicine and public health.
The details
Researchers tracked a cohort of children using nationwide health insurance data from South Korea to compare admission rates between exposed and unexposed groups. The association remained statistically significant even when researchers performed sibling comparisons to control for shared environmental factors.
Timeline
The study examined children born between 2010 and 2017.
The study was published in PLOS Medicine on October 13, 2026.
Culture Shift
This study reflects a growing scientific focus on the long-term pediatric impacts of maternal pharmaceutical use beyond traditional birth outcomes. It marks a departure from short-term neonatal monitoring toward multi-year health surveillance for exposed children.
Parents who received opioid prescriptions during pregnancy may need to coordinate closer health monitoring with their pediatricians, particularly for children under five. This includes staying vigilant for signs of respiratory, gastrointestinal, or infectious conditions.
The takeaway
The study underscores the importance of discussing all prenatal medication use with a healthcare provider to understand potential long-term risks. Clinicians and caregivers should prioritize consistent pediatric checkups for children with a history of prenatal opioid exposure.
Further reading
Learn more about health developments during and after birth in our Pregnancy section.
More information
Read the complete journal study on prenatal opioid exposure for detailed findings.
Live Poll
Should medical providers further restrict opioid prescriptions for pregnant women based on new safety data?
